Finally, having demonstrated the protective effect elicited by AnxA1 postcerebral I/RI coupled with the protection afforded by the protein against cerebral thrombosis (a prerequisite for cerebral ischemia), we determined whether we could further exploit the effects of AnxA1. The gene discussed is ANXA1; the disease is Cerebral ischemia.